Even in the stripped-down form available here, the news is clear enough: the companies are adding to a clinical-trial effort and presenting access as the point. That is a practical claim as much as a corporate one. Clinical research can depend on who is able to reach a site, fit visits into ordinary life and stay engaged through a study, so the placement and number of centers are not trivial details.
The item available through the RSS summary does not provide the locations of the three planned centers, a timetable for opening them or the types of studies they will support. It also does not say how many centers Walmart and Care Access already have in operation together.
Still, the announcement itself is a specific move, not a vague promise: three more clinical trial centers are planned, and the companies are tying that expansion directly to access to medical research.
Harvey Jr. 
Sophia Borg